Enhancer ID: | E_01_0704 |
Species: | human |
Position : | chr8:127397745-127399745 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Oophoroma |
Pubmed ID: | 29435081 |
Enhancer experiment: | Total RNA extraction,RT?qPCR,Small interfering RNAs (siRNAs) and transfection,Monolayer wound healing assay,Transwell invasion assay,Western blot,TOP?FLASH luciferase assay |
Enhancer experiment description: | Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer. |
Target gene : | CCAT2 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer. |
TF name : | -- |
TF experiment: | Total RNA extraction,RT?qPCR,Small interfering RNAs (siRNAs) and transfection,Monolayer wound healing assay,Transwell invasion assay,Western blot,TOP?FLASH luciferase assay |
TF experiment description: | Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer. |
Enhancer function : | Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Thus, CCAT2 might play a critical role in EOC progression and serve as a valuable target for the treatment of ovarian cancer. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|